Abstract
Objective Obsessive-compulsive disorder (OCD) is known to be substantially heritable; however, the contribution of common genetic variation across the allele frequency spectrum to this heritability remains uncertain. We use two new, homogenous cohorts to estimate heritability of OCD from common genetic variation and contrast results with prior studies.
Methods The sample consisted of 2096 Swedish-born individuals diagnosed with OCD and 4609 controls, all genotyped for common genetic variants, specifically >400,000 single nucleotide polymorphisms (SNPs) with minor allele frequency (MAF) ≥ 0.01. Using genotypes of these SNPs to estimate distant familial relationships among individuals, we estimated heritability of OCD, both overall and partitioned according to MAF bins.
Results We estimated narrow-sense heritability of 28% (SE=4%). The estimate was robust, varying only modestly under different models. Contrary to an earlier study, however, SNPs with MAF between 0.01 and 0.05 accounted for 8% of heritability and estimated heritability per bin roughly follows expectations based on a simple model for SNP-based heritability.
Conclusions These results indicate that common inherited risk variation (MAF ≥ 0.01) accounts for most of the heritable variation in OCD. SNPs with low MAF contribute meaningfully to the heritability of OCD and the results are consistent with expectation under the “infinitesimal model,” where risk is influenced by a large number of loci across the genome and across MAF bins.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by a grant from the Friedman Brain Institute (DEG), and the Beatrice and Samuel A. Seaver Foundation (DEG, SS, JDB, BM); the Mindworks Charitable Lead Trust (DEG); the Stanley Center for Psychiatric Research (DEG and JDB); and NIMH grant R01MH124679 (DEG), R37MH057881 (BD/KR) and R01MH110427 (JC); the Swedish Research Council (grant numbers 2015-02271, 2018-02487) (DM-C and CR), CIMED and Region Stockholm (CR). Funding for some of the control samples was from the Anorexia Nervosa Genetics Initiative (ANGI), an initiative of the Klarman Family Foundation (PI: Bulik). Dr. Bulik is also supported by (R01MH120170, R01MH119084 PI: Bulik; U01 MH109528 PI: Sullivan); the Swedish Research Council (Vetenskapsrådet, award: 538-2013-8864); Brain and Behavior Research Foundation Distinguished Investigator Grant; and Lundbeck Foundation (Grant no. R276-2018-4581). The computation was performed on resources provided by SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) under Project sens2018605. LifeGene was supported by the Torsten and Ragnar Söderbergs Foundation, Karolinska Institutet, Stockholm County Council, and AFA Insurance. LifeGene is a core facility at Karolinska Institutet.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approvals were obtained from the Institutional Review Board (IRB) at the Icahn School of Medicine at Mount Sinai, New York, NY, and the Regional Ethical Review Board in Stockholm.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Location of work and address for reprints: Dorothy E. Grice, M.D., Dorothy.Grice{at}mssm.edu 1425 Madison Avenue, New York, NY 10029, phone: 212-659-1670.
Disclosures: Authors report no financial relationships with commercial interests.
Data Availability
The data that support the findings of this study are available on request from the corresponding author, [DEG]. The data are not publicly available.
